Inmed Pharmaceuticals Inc Share Price

NASDAQ: INM

Small Cap

$2.34

+0.02

(+0.86%)

as on September 18, 2025 at 1:28 am IST

$₹

Inmed Pharmaceuticals Inc Stock Performance

as on September 18, 2025 at 1:28 am IST

Day's Low
Day's High
$2.3
Day's Price Range
$2.45
$2.34
1.71%
Downside
4.70%
Upside
52 Week's Low
52 Week's High
$1.72
52-Week Price Range
$8.27
$2.34
26.50%
Downside
253.42%
Upside

Inmed Pharmaceuticals Inc share price movements today

Previous Close: $2.32
Open: $2.36
Volume: 444.8K
Day's Low - High: $2.3 - $2.45
52 Week Low - High: $1.72 - $8.27

Inmed Pharmaceuticals Inc Historical Returns

1 Month Return: 0 %
3 Month Return: -1.69 %
1 Year Return: -54.92 %
3 Year Return: -98.63 %
5 Year Return: 0 %

Inmed Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Inmed Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.51

Industry PE ratio

P/B Ratio

PEG Ratio

EBITDA

-7.9M

Revenue (TTM)

4.9M

Profit Margin

-168.90%

Return On Equity TTM

16387100.00%

Inmed Pharmaceuticals Inc Stock Valuation

Track how Inmed Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.

Inmed Pharmaceuticals Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 17, 2025

Industry (0.00x)

September 17, 2025

Today (-0.51x)

September 17, 2025

Highest (-0.35x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: -0.51x

Inmed Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Inmed Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Inmed Pharmaceuticals Inc	SELL	$4.4M	NA	-0.51	-168.90%

Stock Returns calculator for Inmed Pharmaceuticals Inc Stock including INR - Dollar returns

The Inmed Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Inmed Pharmaceuticals Inc investment value today

Current value as on today

₹50,035

Returns

₹49,965

(-49.96%)

Returns from Inmed Pharmaceuticals Inc Stock

₹54,563 (-54.56%)

Dollar Returns*

₹4,598 (+4.6%)

Analyst Recommendation on Inmed Pharmaceuticals Inc Stock

Based on 8 analysts

SELL

0.00%

Buy

37.50%

Hold

62.50%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'SELL' rating for Inmed Pharmaceuticals Inc. Average target price of $20

Inmed Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Inmed Pharmaceuticals Inc.

What analysts predicted

88.3%UPSIDE

Target Price

$20

Current Price

$2.34

Analyzed by

8 Analysts

Target

$20.00

Inmed Pharmaceuticals Inc target price $20, a slight upside of 88.3% compared to current price of $2.34. According to 8 analysts rating.

Inmed Pharmaceuticals Inc Stock's Interest Amongst Investors

Search interest for Inmed Pharmaceuticals Inc Stock has decreased by -20% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-20% versus previous 30 day period

Inmed Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Total Revenue	0	1	1	0	1	1	1	1	1	1
Gross Profit	0	0	1	0	0	0	0	0	0	0
Operating Income	-3	-2	-8,168	0	-2	-2	-2	-2	-3	-3
EBITDA	-2	-2	0	-3	-1	-2	-2	-2	-3	-2
Interest Expense	0	102	102	102	-	-	-	-	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-2	-2	0	-3	-1	-2	-2	-2	-3	-3
Income Tax Expense	0	0	0	0	0	0	0	-	-	-
Net Income	-2	-1	0	-2	-1	-1	-1	-1	-3	-3
Net Profit Margin	-447.25%	-193.24%	-14.64%	-281.29%	-119.19%	-146.93%	-151.02%	-132.68%	-231.63%	-168.12%

Inmed Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Total Revenue	-	-	-	-	-	1	4	4
Gross Profit	-	0	0	0	0	0	1	1
Operating Income	-3	-6	-10	-8	-9	-17	-11	-11
EBITDA	-3	-6	-10	-8	-9	-17	-10	-10
Interest Expense	0	0	0	0	0	0	-	-
Depreciation	0	0	0	0	0	0	0	0
Income Before Tax	-3	-6	-10	-8	-10	-23	-10	-10
Income Tax Expense	0	0	0	0	0	4	0	0
Net Income	-2	-5	-7	-6	-8	-18	-7	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-1707.32%	-192.18%	-166.94%

Inmed Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Income	-1	-2	-1	-1	-1	-1	-2	-6,369
Operating Cash Flow	-1	-2	-1	-1	-1	-1,826	1,822	-5,984
Investing Cash Flow	0	0	0	0	0	-	-	-
Financing Cash Flow	0	0	4	0	0	838	-837	4,095
Change in Cash	-1	-2	2	-1	-1	-988	-2	4,676

Inmed Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024
Net Income	-1	-3	-6	-10	-8	-10	-18	-7	-7
Operating Cash Flow	0	-2	-3	-6	-7	-9	-15	-7	-6
Investing Cash Flow	0	0	-1	-2	3	0	0	0	0
Financing Cash Flow	0	7	19	0	0	10	15	10	4
Change in Cash	0	5	13	-8	-3	1	-1	2	-2

Global Institutional Holdings in Inmed Pharmaceuticals Inc

Funds	Holdings
UBS Group AG	0.51%
SBI Securities Co Ltd	0.02%
Banque Cantonale Vaudoise	0%
Federation des caisses Desjardins du Quebec	0%
AllSquare Wealth Management LLC	0%

See all

Insights on Inmed Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.70M → -3.02M (in $), with an average increase of 22.6% per quarter
POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 21.39% to 21.76% in Mar 2025 quarter
POSITIVE IMPACT
Price Rise
In the last 1 month, INM stock has moved up by 22.4%
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 1.59M → 1.79M (in $), with an average increase of 11.0% per quarter
POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 69.93% to 70.26% in Mar 2025 quarter
NO EFFECT
Against Peers
In the last 1 year, United Therapeutics Corporation has given 15.3% return, outperforming this stock by 70.2%
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation has given 82.5% return, outperforming this stock by 181.1%
NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 8.68% to 7.99% in Mar 2025 quarter
NEGATIVE IMPACT
Price Dip
In the last 1 year, INM stock has moved down by -54.9%

About Inmed Pharmaceuticals Inc

inmed is a clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. inmed's proprietary platform technology, product pipeline and accelerated development pathway are the fundamental value drivers of the company.

Organisation	Inmed Pharmaceuticals Inc
Headquarters	885 West Georgia Street, Vancouver, BC, Canada, V6C 3E8
Industry	Health Technology
CEO	Mr. Eric A. Adams B.S. Chem., M.I.B.
E-voting on shares	Click here to vote

Key Management of Inmed Pharmaceuticals Inc

Name	Title
Mr. Michael Woudenberg P.Eng.	Chief Operating Officer
Dr. Eric Chih-Hsien Hsu Ph.D.	Senior Vice President of Preclinical Research & Development
Colin Clancy	Senior Director of Investor Relations
Mr. Jerry P. Griffin	Vice President of Sales & Marketing
Dr. Shane A. Johnson Ph.D.	Senior VP & GM of BayMedica
Mr. Eric A. Adams B.S. Chem., M.I.B.	President, CEO & Director
Ms. Alexandra Diane-Janet Mancini M.Sc.	Senior Vice President of Clinical & Regulatory Affairs
Dr. Sazzad Hossain M.Sc., Ph.D.	Co-Founder
Dr. Ado Muhammad	Senior Consultant of Medical Affairs
Ms. N. Netta Jagpal	CFO & Corporate Secretary

FAQs

What is Inmed Pharmaceuticals Inc share price today?

Inmed Pharmaceuticals Inc share price today is $2.34 as on September 18, 2025 at 1:28 am IST at the close of the market. Inmed Pharmaceuticals Inc share today touched a day high of $2.45 and a low of $2.3.

What is the 52 week high and 52 week low for Inmed Pharmaceuticals Inc share?

Inmed Pharmaceuticals Inc share touched a 52 week high of $8.27 on January 21, 2025 and a 52 week low of $1.72 on April 7, 2025. Inmed Pharmaceuticals Inc stock price today i.e. September 18, 2025 at 1:28 am IST is closed at $2.34,which is 71.70% down from its 52 week high and 36.05% up from its 52 week low.

What is Inmed Pharmaceuticals Inc's market capitalisation today?

Inmed Pharmaceuticals Inc market capitalisation is $0.00T as on September 18, 2025 at 1:28 am IST.

How to invest in Inmed Pharmaceuticals Inc Stock (INM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Inmed Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Inmed Pharmaceuticals Inc Shares that will get you 0.6410 shares as per Inmed Pharmaceuticals Inc share price of $2.34 per share as on September 18, 2025 at 1:28 am IST.

What is the minimum amount required to buy Inmed Pharmaceuticals Inc Stock (INM) from India?

Indian investors can start investing in Inmed Pharmaceuticals Inc (INM) shares with as little as ₹87.816 or $1 (as of September 18, 2025 at 3:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Inmed Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 3:39 am IST). Based on Inmed Pharmaceuticals Inc share’s latest price of $2.34 as on September 18, 2025 at 1:28 am IST, you will get 4.2735 shares of Inmed Pharmaceuticals Inc. Learn more about fractional shares .